Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Geoffrey Colby

Neurological Surgery Los Angeles, CA Medical Doctor

NPI 1144373739 CMS profile 6760

300 Medical Plaza, Los Angeles, CA 90095

Open in the dashboard

General payments

$1,080,299

1,193 records reported · program years 2019–2025

Research payments

$30,888

Paid to them · 14 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$45,429 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Geoffrey Colby of Los Angeles, CA is reported in the CMS Open Payments database as having received $1,080,299 across 1,193 general payments and $30,888 in research payments paid to them. Separately, studies naming them as principal investigator received $45,429 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $115,237 94
2025 Research $13,663 6
2024 General $118,657 120
2024 Research $10,555 5
2023 General $157,958 200
2023 Research $6,670 3
2022 General $128,647 138
2021 General $192,761 216
2020 General $182,371 224
2019 General $184,668 201

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Geoffrey Colby
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Geoffrey Colby were reported at $115,237. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Geoffrey Colby Neurological Surgery median Middle half National median
2019 $184,668 $582 $138–$3,006 $163
2020 $182,371 $294 $76–$2,174 $114
2021 $192,761 $387 $105–$2,432 $132
2022 $128,647 $542 $139–$2,989 $149
2023 $157,958 $534 $145–$2,697 $160
2024 $118,657 $574 $155–$3,046 $164
2025 $115,237 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $650,514 671 payments
  2. MicroVention, Inc. $287,837 352 payments
  3. Medtronic USA, Inc. $61,771 53 payments
  4. Medtronic, Inc. $30,899 37 payments
  5. Rapid Medical LTD $30,762 35 payments
  6. Medical Device Business Services, Inc. $7,191 11 payments
  7. DePuy Synthes Products, Inc. $5,365 2 payments
  8. Balt USA, LLC $3,398 12 payments
  9. DePuy Synthes Sales Inc. $434 6 payments
  10. Penumbra, Inc. $427 3 payments
  11. Other $1,700 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $639,212 168 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $276,469 109 payments
  3. Travel and Lodging $139,427 523 payments
  4. Food and Beverage $24,791 392 payments
  5. Honoraria $400 1 payment
Products named General payments · program years 2019–2025
  1. SURPASS EVOLVE $272,980 279 payments
  2. SURPASS $162,880 134 payments
  3. WEB $99,330 154 payments
  4. WEB Aneurysm Embolization System Neurological Product $95,800 92 payments
  5. WEB ANEURYSM EMBOLIZATION SYSTEM Neurological Product $83,009 91 payments
  6. Pipeline $60,320 48 payments
  7. TARGET $52,809 62 payments
  8. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $30,162 34 payments
  9. COMANECI 17 $26,562 34 payments
  10. NEUROFORM EZ 3 $20,894 4 payments
  11. Other $215,331 295 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $26,825 12 payments
  2. Nuvascular Inc. $4,063 2 payments

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$86,080

Medicare's payments for the services billed

Medicare patients

205

Average age 73

Services billed

543

128 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 47%
Ischemic heart disease 34%
Diabetes 32%
Osteoporosis 29%
Depression 28%
Cancer 22%
Chronic kidney disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,207 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record